130 related articles for article (PubMed ID: 29911771)
1. [The inhibition of carboxylesterases by praeruptorin C, D and E].
Du Z; Chen DW; Fu ZW; Fang ZZ; Yang K
Yao Xue Xue Bao; 2017 Jan; 52(1):66-70. PubMed ID: 29911771
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the inhibition of human carboxylesterases (CESs) by the active ingredients from
Fu Q; Yang K; Hu RX; Du Z; Hu CM; Zhang X
Xenobiotica; 2019 Nov; 49(11):1260-1268. PubMed ID: 30486721
[TBL] [Abstract][Full Text] [Related]
3. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
[TBL] [Abstract][Full Text] [Related]
4. Per- and polyfluoroalkyl substances exert strong inhibition towards human carboxylesterases.
Liu YZ; Pan LH; Bai Y; Yang K; Dong PP; Fang ZZ
Environ Pollut; 2020 Aug; 263(Pt A):114463. PubMed ID: 32283456
[TBL] [Abstract][Full Text] [Related]
5. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
[TBL] [Abstract][Full Text] [Related]
6. Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597.
Crow JA; Bittles V; Borazjani A; Potter PM; Ross MK
Biochem Pharmacol; 2012 Nov; 84(9):1215-22. PubMed ID: 22943979
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon.
Crow JA; Bittles V; Herring KL; Borazjani A; Potter PM; Ross MK
Toxicol Appl Pharmacol; 2012 Jan; 258(1):145-50. PubMed ID: 22100607
[TBL] [Abstract][Full Text] [Related]
8. Inhibition behavior of fructus psoraleae's ingredients towards human carboxylesterase 1 (hCES1).
Sun DX; Ge GB; Dong PP; Cao YF; Fu ZW; Ran RX; Wu X; Zhang YY; Hua HM; Zhao Z; Fang ZZ
Xenobiotica; 2016; 46(6):503-10. PubMed ID: 26560012
[TBL] [Abstract][Full Text] [Related]
9. Carboxylesterase Inhibitors: An Update.
Zou LW; Jin Q; Wang DD; Qian QK; Hao DC; Ge GB; Yang L
Curr Med Chem; 2018; 25(14):1627-1649. PubMed ID: 29210644
[TBL] [Abstract][Full Text] [Related]
10. The Inhibition of UDP-Glucuronosyltransferase (UGT) Isoforms by Praeruptorin A and B.
Liu X; Chen DW; Wu X; Zhao Z; Fu ZW; Huang CT; Ye LX; Du Z; Yu Y; Fang ZZ; Sun HZ
Phytother Res; 2016 Nov; 30(11):1872-1878. PubMed ID: 27534594
[TBL] [Abstract][Full Text] [Related]
11. Hydroxylated polychlorinated biphenyls (OH-PCBs) exert strong inhibitory effects towards human carboxylesterases (CESs).
Sun HZ; Qin GQ; Wang FG; Bai Y; Zhang Z; Fang ZZ
Sci Total Environ; 2020 Nov; 745():141140. PubMed ID: 32736114
[TBL] [Abstract][Full Text] [Related]
12. Effects of alcohol on human carboxylesterase drug metabolism.
Parker RB; Hu ZY; Meibohm B; Laizure SC
Clin Pharmacokinet; 2015 Jun; 54(6):627-38. PubMed ID: 25511794
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids.
Crow JA; Herring KL; Xie S; Borazjani A; Potter PM; Ross MK
Biochim Biophys Acta; 2010 Jan; 1801(1):31-41. PubMed ID: 19761868
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the inhibitory effects of pyrethroids against human carboxylesterases.
Lei W; Wang DD; Dou TY; Hou J; Feng L; Yin H; Luo Q; Sun J; Ge GB; Yang L
Toxicol Appl Pharmacol; 2017 Apr; 321():48-56. PubMed ID: 28242322
[TBL] [Abstract][Full Text] [Related]
15. Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.
Wong CC; Cheng KW; Xie G; Zhou D; Zhu CH; Constantinides PP; Rigas B
J Pharmacol Exp Ther; 2012 Feb; 340(2):422-32. PubMed ID: 22085648
[TBL] [Abstract][Full Text] [Related]
16. Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase.
Shimizu M; Fukami T; Nakajima M; Yokoi T
Drug Metab Dispos; 2014 Jul; 42(7):1103-9. PubMed ID: 24751575
[TBL] [Abstract][Full Text] [Related]
17. Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver.
Sato Y; Miyashita A; Iwatsubo T; Usui T
Drug Metab Dispos; 2012 May; 40(5):902-6. PubMed ID: 22293119
[TBL] [Abstract][Full Text] [Related]
18. Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril.
Zhu HJ; Appel DI; Johnson JA; Chavin KD; Markowitz JS
Biochem Pharmacol; 2009 Apr; 77(7):1266-72. PubMed ID: 19185566
[TBL] [Abstract][Full Text] [Related]
19. Different inhibitory effects in rat and human carboxylesterases.
Takahashi S; Katoh M; Saitoh T; Nakajima M; Yokoi T
Drug Metab Dispos; 2009 May; 37(5):956-61. PubMed ID: 19225040
[TBL] [Abstract][Full Text] [Related]
20. Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review.
Liu Y; Li J; Zhu HJ
Expert Opin Drug Metab Toxicol; 2024 May; 20(5):377-397. PubMed ID: 38706437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
